Technical Analysis for CUE - Cue Biopharma, Inc.

Grade	Last Price	% Change	Price Change
	8.8	-2.11%	-0.19

CUE closed down 2.11 percent on Friday, November 15, 2019, on 50 percent of normal volume.

ADX	Long-Term	Intermediate-Term	Short-Term
Weak or Absent	Up	Up	Flat
See historical CUE trend table...

Date	Alert Name	Type	% Chg
Nov 14	Pocket Pivot	Bullish Swing Setup	-2.11%
Nov 14	NR7	Range Contraction	-2.11%
Nov 14	Inside Day	Range Contraction	-2.11%
Nov 14	Overbought Stochastic	Strength	-2.11%
Nov 13	Bearish Engulfing	Bearish	0.23%
Nov 13	Stochastic Sell Signal	Bearish	0.23%
Nov 13	Overbought Stochastic	Strength	0.23%
Nov 12	Overbought Stochastic	Strength	-3.51%
Nov 12	Up 3 Days in a Row	Strength	-3.51%
Nov 11	Pocket Pivot	Bullish Swing Setup	-1.79%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Biotechnology Biopharmaceutical Health Cancer Life Sciences Pharmaceutical Industry Medication Pharmacy Cancers Specialty Drugs Autoimmunity Autoimmune Disorders

Indicator	Bull Case	Neutral / Hold	Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary:	Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Date	Title
Nov 15	What Makes Cue Biopharma, Inc. (CUE) a New Strong Buy Stock
Nov 12	Cue Biopharma EPS beats by $0.13
Nov 12	Cue Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights
Nov 6	Cue Biopharma to Present at Upcoming Investor Conferences in November 2019
Nov 3	Here's Why We're Watching Cue Biopharma's (NASDAQ:CUE) Cash Burn Situation
Oct 30	Cue Biopharma Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
Oct 15	Cue Biopharma to Present at the Oppenheimer Houston Oncology Summit at the University of Texas MD Anderson Cancer Center
Oct 9	Cue Biopharma Announces Changes to its Board of Directors
Oct 9	Cue Biopharma to Present at Upcoming October 2019 Scientific Conferences
Oct 7	New operating chief at Cue Bio

Pivot Point Level	Traditional / Classic	Fibonacci	Demark	Woodie	Camarilla
Resistance 4 (R4)					9.33
Resistance 3 (R3)	9.38	9.26			9.24
Resistance 2 (R2)	9.26	9.13		9.23	9.21
Resistance 1 (R1)	9.03	9.04	8.97	8.98	9.18
Pivot Point	8.91	8.91	8.88	8.88	8.91
Support 1 (S1)	8.68	8.78	8.62	8.63	8.42
Support 2 (S2)	8.56	8.69		8.53	8.39
Support 3 (S3)	8.33	8.56			8.36
Support 4 (S4)					8.28